Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_assertion type Assertion NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_head.
- NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_assertion description "[Pallidal DBS was well tolerated and highly effective, with mean Burke-Fahn-Marsden Dystonia Rating Scale movement scores improving from baseline by 61.5% (P < .001) at 1 year, 64.4% (P < .001) at 2 years, and 70.3% (P < .001) at the final follow-up visit (mean, 32 months; range, 7-77 months).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_provenance.
- NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_assertion evidence source_evidence_literature NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_provenance.
- NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_assertion SIO_000772 22811083 NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_provenance.
- NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_assertion wasDerivedFrom befree-20140225 NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_provenance.
- NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_assertion wasGeneratedBy ECO_0000203 NP588053.RA4r2T8J9-PTsVFDBWAksRN_NCNutgZoBbtu4joUjakDo130_provenance.